Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

National Health Investors (NY: NHI )

76.45 -0.20 (-0.26%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about National Health Investors

< Previous 1 2 3 4 5 Next >
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces Third Quarter 2024 Earnings Release and Conference Call Dates
Via ACCESSWIRE
Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session
Via Benzinga
NHI Announces Pricing of Upsized Public Offering of Common Stock
Via ACCESSWIRE
NHI Announces Public Offering Of Common Stock
Via ACCESSWIRE
NHI Announces Third Quarter 2024 Dividend
Via ACCESSWIRE
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces Second Quarter 2024 Results
Via ACCESSWIRE
Mortgage Applications Rocket By 16.8%, Notch Strongest Weekly Increase In 1.5 Years: 'Homebuyers Took The Opportunity To Refinance'
Mortgage applications surge 16.8%, refinance activity at highest since 2022. Mortgage-linked stocks reach record levels. Top-performing stocks listed. 
Via Benzinga
NHI Stock Earnings: National Health Investors Beats Revenue for Q2 2024
NHI stock results show that National Health Investors beat on revenue for the second quarter of 2024. 
Via InvestorPlace
NHI Announces Second Quarter 2024 Earnings Release and Conference Call Date
Via ACCESSWIRE
What Analysts Are Saying About National Health Investors Stock
Via Benzinga
NHI Files Supplemental Proxy
Via ACCESSWIRE
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces Second Quarter 2024 Dividend
Via ACCESSWIRE
NHI Announces First Quarter 2024 Results
Via ACCESSWIRE
Beyond The Numbers: 4 Analysts Discuss National Health Investors Stock
Via Benzinga
NHI Stock Earnings: National Health Investors Reported Results for Q1 2024
National Health Investors just reported results for the first quarter of 2024. 
Via InvestorPlace
NHI Announces First Quarter 2024 Earnings Release and Conference Call Date
Via ACCESSWIRE
Deep Dive Into National Health Investors Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
The 7 Most Undervalued REITs to Buy in April 2024
Uncover seven REITs with compelling valuations and high-income potential, ready to enhance your portfolio this April. 
Via InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Real Estate Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
NHI Issues Investor Update
Via ACCESSWIRE
NHI Announces First Quarter 2024 Dividend
Via ACCESSWIRE
NHI Announces Fourth Quarter 2023 Results
Via ACCESSWIRE
Senior Housing Sector Is Reviving, Analyst Forecasts Growth For National Health Investors
BMO Capital Markets upgrades National Health Investors to Outperform, citing potential for multiple expansions, SHOP growth, and acquisitions. 
Via Benzinga
Analysts See Upside On These 3 REITs
Via Benzinga
Block To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Analyst Initiates Coverage On 10 Healthcare REITs, But Which Ones Are Buys?
Via Benzinga
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.